Free Trial

Marsh & McLennan Companies, Inc. (NYSE:MMC) Shares Sold by Fulton Breakefield Broenniman LLC

Marsh & McLennan Companies logo with Finance background

Fulton Breakefield Broenniman LLC trimmed its position in Marsh & McLennan Companies, Inc. (NYSE:MMC - Free Report) by 1.9% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 66,178 shares of the financial services provider's stock after selling 1,267 shares during the quarter. Marsh & McLennan Companies makes up 1.2% of Fulton Breakefield Broenniman LLC's investment portfolio, making the stock its 27th largest position. Fulton Breakefield Broenniman LLC's holdings in Marsh & McLennan Companies were worth $16,149,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of MMC. Vanguard Group Inc. raised its stake in Marsh & McLennan Companies by 0.8% during the 4th quarter. Vanguard Group Inc. now owns 44,739,515 shares of the financial services provider's stock worth $9,503,120,000 after acquiring an additional 356,618 shares in the last quarter. Geode Capital Management LLC raised its stake in Marsh & McLennan Companies by 1.2% during the 4th quarter. Geode Capital Management LLC now owns 12,050,565 shares of the financial services provider's stock worth $2,554,841,000 after acquiring an additional 145,134 shares in the last quarter. Price T Rowe Associates Inc. MD raised its stake in Marsh & McLennan Companies by 1.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 10,151,020 shares of the financial services provider's stock worth $2,156,179,000 after acquiring an additional 96,750 shares in the last quarter. Northern Trust Corp raised its stake in Marsh & McLennan Companies by 14.0% during the 4th quarter. Northern Trust Corp now owns 5,934,340 shares of the financial services provider's stock worth $1,260,513,000 after acquiring an additional 726,713 shares in the last quarter. Finally, Norges Bank acquired a new stake in Marsh & McLennan Companies during the 4th quarter worth $1,236,186,000. 87.99% of the stock is currently owned by institutional investors and hedge funds.

Marsh & McLennan Companies Price Performance

Shares of NYSE MMC traded down $3.09 on Friday, hitting $211.62. The company's stock had a trading volume of 2,234,444 shares, compared to its average volume of 1,980,081. Marsh & McLennan Companies, Inc. has a 12-month low of $207.21 and a 12-month high of $248.00. The company has a market capitalization of $104.27 billion, a price-to-earnings ratio of 25.93, a price-to-earnings-growth ratio of 2.59 and a beta of 0.80. The company has a debt-to-equity ratio of 1.32, a current ratio of 1.14 and a quick ratio of 1.14. The stock has a 50 day moving average of $222.70 and a 200-day moving average of $224.76.

Marsh & McLennan Companies (NYSE:MMC - Get Free Report) last announced its quarterly earnings results on Thursday, April 17th. The financial services provider reported $3.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.02 by $0.04. Marsh & McLennan Companies had a net margin of 16.13% and a return on equity of 32.19%. The company had revenue of $6.70 billion for the quarter, compared to the consensus estimate of $7.08 billion. During the same quarter in the prior year, the firm earned $2.89 earnings per share. As a group, research analysts predict that Marsh & McLennan Companies, Inc. will post 9.61 EPS for the current year.

Marsh & McLennan Companies Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 15th. Stockholders of record on Thursday, July 24th will be given a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a dividend yield of 1.70%. The ex-dividend date is Thursday, July 24th. This is a positive change from Marsh & McLennan Companies's previous quarterly dividend of $0.82. Marsh & McLennan Companies's payout ratio is currently 39.95%.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on MMC. Keefe, Bruyette & Woods cut their price target on shares of Marsh & McLennan Companies from $215.00 to $214.00 and set an "underperform" rating on the stock in a research note on Wednesday. UBS Group lifted their price objective on shares of Marsh & McLennan Companies from $259.00 to $261.00 and gave the company a "buy" rating in a research note on Wednesday, April 9th. Wells Fargo & Company lifted their price objective on shares of Marsh & McLennan Companies from $228.00 to $229.00 and gave the company an "equal weight" rating in a research note on Thursday. Barclays dropped their price objective on shares of Marsh & McLennan Companies from $249.00 to $233.00 and set an "equal weight" rating on the stock in a research note on Monday, July 7th. Finally, Redburn Atlantic initiated coverage on shares of Marsh & McLennan Companies in a research note on Tuesday, March 25th. They issued a "buy" rating and a $281.00 price objective on the stock. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, Marsh & McLennan Companies presently has an average rating of "Hold" and an average target price of $240.50.

Read Our Latest Report on MMC

Marsh & McLennan Companies Company Profile

(Free Report)

Marsh & McLennan Cos., Inc is a professional services firm, which engages in offering clients advice and solutions in risk, strategy, and people. It operates through the Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment is involved in risk management activities, as well as insurance and reinsurance broking and services.

Featured Articles

Institutional Ownership by Quarter for Marsh & McLennan Companies (NYSE:MMC)

Should You Invest $1,000 in Marsh & McLennan Companies Right Now?

Before you consider Marsh & McLennan Companies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh & McLennan Companies wasn't on the list.

While Marsh & McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Watch Before Monday: Stocks to Load Up on Before Earnings
3 Hot Growth Stocks to Watch Right Now!
Don’t Miss These Top 3 Defense Stocks Set To Gain

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines